Low-Level Laser Therapy Reduces Lung Inflammation in an Experimental Model of Chronic Obstructive Pulmonary Disease Involving P2X7 Receptor

" Our results showed that LLLT significantly reduced the number of inflammatory cells and the proinflammatory cytokine secretion such as IL-1β, IL-6, and TNF-α in bronchoalveolar lavage fluid (BALF). We also observed that LLLT decreased collagen deposition as well as the expression of purinergic P2X7 receptor. On the other hand, LLLT increased the IL-10 release. Thus, LLLT can be pointed as a promising therapeutic approach for lung inflammatory diseases as COPD." {Credits 1}

{Credits 1} 🎪 da Cunha Moraes, G., Vitoretti, L. B., de Brito, A. A., Alves, C. E., de Oliveira, N. C. R., dos Santos Dias, A., ... & Candeo, L. C. (2018). Low-level laser therapy reduces lung inflammation in an experimental model of chronic obstructive pulmonary disease involving P2X7 receptor. Oxidative medicine and cellular longevity, 2018. Copyright © 2018 Gabriel da Cunha Moraes et al. This is an open access article distributed under the Creative Commons Attribution License.